Register Now
Course Information

About the Symposium

This unique day-and-a-half symposium will focus on in-depth pathophysiology of diabetes and biology of beta cells. It also features significant advances in the field of basic and clinical science related to treatment of diabetes with beta cell and solid pancreas transplant. It will review prevention, as well as the newest technologies available for Type-1 diabetes, including technological advancements from both the biologic and device technology fields, discussing challenges, opportunities and future directions.

By providing relevant discussions of the most current evidence, this educational offering strives to help practitioners acquire knowledge and skills regarding new data and technology which, in turn, can be translated directly to their clinical practice. Our goal is to improve the quality of patient care and enhance the level of information available to the physicians and other providers involved in diagnosis and treatment at the local, national and international level.

Learning Objectives

  • Review the pathophysiology of Type-1 and Type-2 diabetes.
  • Describe the underlying mechanisms of islet cell dysfunction in diabetes.
  • Recognize recent advances in beta cell therapy.
  • Indicate recent biotechnical advances in the treatment of Type-1 and Type-2 diabetes.
  • Discuss novel immunosuppressive and immune-modulatory protocols for solid pancreas and islet cell therapy.
  • Review the current status of the long term therapeutic efficacy of solid pancreas transplant alone or combined with kidney.

Target Audience

Endocrinology, Family Practice, Gastroenterology, Internal Medicine, Pediatrics, Surgery, Urology, Residents, Fellows, Nursing, Physician Assistant, and Allied Health Professionals.